Singapore markets closed
Straits Times Index
3,187.66 +32.97 (+1.05%) S&P 500
5,049.52 +27.31 (+0.54%) Dow
38,052.43 +299.12 (+0.79%) Nasdaq
15,753.97 +70.60 (+0.45%) Bitcoin USD
63,924.35 +2,596.04 (+4.23%) CMC Crypto 200
885.54 0.00 (0.00%)
Lotus Pharmaceutical Co., Ltd. (1795.TW)
Taiwan - Taiwan Delayed price. Currency in TWD
Add to watchlist
At close: 01:30PM CST
| Previous close | 333.50 |
| Open | 330.50 |
| Bid | 320.50 x N/A |
| Ask | 321.00 x N/A |
| Day's range | 319.00 - 333.50 |
| 52-week range | 205.00 - 349.50 |
| Volume | |
| Avg. volume | 6,807,006 |
| Market cap | 84.894B |
| Beta (5Y monthly) | 0.52 |
| PE ratio (TTM) | 20.49 |
| EPS (TTM) | 15.67 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | 3.46 (1.04%) |
| Ex-dividend date | 05 Jul 2023 |
| 1y target est | 433.33 |
- Business Wire
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY® in Multiple Markets Across Asia
BOSTON & TAIPEI, Taiwan, August 10, 2023--Corium, LLC ("Corium"), a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and Lotus Pharmaceutical (1795:TT; "Lotus"), a multinational pharmaceutical company, announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY® (donepezil transdermal system), an innovative Alzheimer’s dementia treatment, in ten markets across Asia.
© 2024 Yahoo. All rights reserved.